China Blocks Pharma’s Herbal Injection After Three Deaths
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities moved to block an herbal injection made by a pharmaceutical firm after three patients died of strong adverse reactions to the Siberian ginseng treatment made by Wandashan Pharmaceuticals. The State FDA ordered use and distribution of the injection suspended after the adverse reactions reported in a single province of the nation. The herbal injections are used to treat thrombosis resulting from weak livers or kidneys, and for curing heart problems. (Click here for more